Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.
Saved in:
| Title: | Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells. |
|---|---|
| Authors: | Benjamin DI; †Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California 94720, United States., Li DS; †Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California 94720, United States., Lowe W; †Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California 94720, United States., Heuer T; ‡3V Biosciences, Inc., 1050 Hamilton Ct., Menlo Park, California 94025, United States., Kemble G; ‡3V Biosciences, Inc., 1050 Hamilton Ct., Menlo Park, California 94025, United States., Nomura DK; †Program in Metabolic Biology, Department of Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, California 94720, United States. |
| Source: | ACS chemical biology [ACS Chem Biol] 2015 Jul 17; Vol. 10 (7), pp. 1616-23. Date of Electronic Publication: 2015 Apr 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
